NEVVI Medicare utilization intelligence
+ Build a code basket
65755 Penetrating transplantation of tissue from 1 cornea to other cornea (in pseudophakia) CPT · Eye procedure
Classification Procedure Eye (CMS RBCS)
First observed 2013 — start of our 12-year window; the code predates it
National scale 348 services ▲ 11.2% YoY · 333 beneficiaries (CY2024, Medicare FFS)
Medicare paid $424K · $1219.81 avg / service, national
CMS descriptor · RBCS classification · Medicare Part B physician/supplier claims, 12-year window · National figures — the KS market is below
Market analyticsPlatform Methods →

The structure and trend panels below are live for everyone — free to look at. The rank & score analytics, baskets, and export are the platform.

The read
What am I looking at, in one breath?
The read Platform

In Kansas, 1 group bills 65755 — 15 fee-for-service services, and volume is up 7.1% year over year.

premium
Unlock the Platform — the full read, every number below, code baskets, and export. Looking is free; the depth is paid. Notify me at launch →

The orienting line is free; the comparative synthesis — growth rank, concentration, and $/service against the national figure — unlocks with Platform.

The snapshot
The honest, real numbers — free, always.
Billing groups

1

Named groups billing this code in KS
Named-group FFS services

15

Attributable volume · fee-for-service
FFS of Medicare

67%

Payer-mix frame
Named-group coverage

57%

Of Kansas’s disclosed Part B services (2024). The rest is billed by clinicians whose volume isn’t attributed to any group — they belong to several groups, or none. How attribution works →
Services · year over year
Services YoY

+7.1%

FFS enrollment -1.1%
Volume, not care. A shrinking fee-for-service denominator is not a shrinking market.
Estimated all-Medicare volume estimate
FFS + estimated MA

~22 services

15 observed fee-for-service (68%) · ~7 estimated Medicare Advantage.

Scaled from the observed floor by each state’s fee-for-service share (FFS share as of 2024) — scaled estimate — assumes MA utilization mirrors FFS; not an observation. How we scale
The market
How big, moving which way, worth how much.
Billed → allowed → paid
Named-group submitted charges
$49K
Named-group allowed amount
$17K
Named-group Medicare payments
$14K
Avg charge / svc
$3,250
Avg allowed / svc
$1,147
Avg payment / svc
$902
Totals are named-group (attributable) sums. Allowed is Medicare’s fee-schedule recognized price — what CMS recognizes, before the 80% Medicare pays.
Per-service vs national + the payments trend unlock with Platformpremium
Market trend — 12-year view
services 2013–2024
YearServices Services per 1,000 Part B FFS beneficiaries Medicare payments
2013 (introduction year) 74 0.2 $77,374
2014 29 0.1 $33,753
2015 53 0.1 $57,487
2016 57 0.1 $66,723
2017 37 0.1 $42,107
2018 42 0.1 $49,726
2019 17 0.0 $22,764
2020 (2020) 17 0.0 $23,987
2021 15 0.0 $21,485
2022 46 0.1 $52,398
2023 28 0.1 $34,881
2024 30 0.1 $36,545

CAGR 2014–2024: +0.3%/yr · CAGR excludes 2020 and the introduction year.

Rates are per 1,000 Part B fee-for-service beneficiaries in the market's geography. See Methods.

The structure
Who's in this market and how it's shaped.
Market structure

Concentration is not shown for markets under 11 billing groups.

Of volume attributable to named groups, independents account for 100%; hospital-affiliated 0%.

Disclosed setting mix: 0% office · 100% facility.

HHI trend: (group rosters begin 2019)

Provider-setting count 2013 → 2024: 5 → 2 (-60%).

Named groups cover 50% of disclosed volume. CMS suppresses provider-code rows under 11 beneficiaries at the source; suppressed volume is excluded and cannot be estimated from this file. Volume shares describe the volume attributable to named groups; the coverage line above states how much of disclosed Medicare fee-for-service volume that is.

Market positionpremium

Where this market sits on volume and growth among all state markets, and its rank.

National benchmarkspremium

Where each group's volume sits nationally and within its specialty.

The opportunity
So where do I act?
Worth a lookpremium

Every state market for this search, ranked by a published score: size, growth, fragmentation, below-expected volume. The cross-market compare view sits alongside.

Or just look at it: nuclear heart imaging (78452) in Arizona is open as a live example — the full paid view, real data.

View the live example →
Refine: group size any 5+ locked column25+ locked column100+ locked column independent only locked column
Filter results:

Email me this CSV

Data year: CY2024 CY2023 CY2022 locked column CY2021 locked column CY2020 locked column
Physician groups ranked by 65755 services, highest first, CY2024
# Physician group locked column City locked column Specialty locked column Providers locked column 65755 svcs Submitted charges locked column Avg charge locked column Medicare $ locked column Share* locked column Phone
1 CAVANAUGH EYE CENTER PA TOPEKA OPHTHALMOLOGY 2 15 $48,750 $3,250 premium 50.0% (913) 897-9200

*Share of the state's disclosed Medicare-FFS services for the primary code, counted once per clinician. "St" is the state the volume was billed from: a group appears in each state where its clinicians bill Medicare, with that state's volume and share ("City" is the group's registered location). Group figures sum clinicians affiliated with exactly one group; clinicians in several groups are listed in each group's drill-down but not volume-attributed to any single group, so shares reflect attributable volume. See Methods.

Comparing against an all-payer estimate?

These are exact counts from Medicare fee-for-service claims — roughly a third to half of most procedure markets, depending on payer mix. Modeled all-payer databases project the remainder statistically; we publish the audited floor and label it as such. Same market, different denominator. How the numbers reconcile →